KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma

BACKGROUND: The platinum-based chemotherapy is the first-line regimen for the treatment of Non-small cell lung cancer (NSCLC). However, the therapeutic efficiency is largely limited by tenacious chemo-insensitivity that results in inferior prognosis in a cohort of patients. It has been known that KI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Boshi, Jing, Tiantian, Jin, Weilin, Chen, Jinnan, Wu, Chengsi, Wang, Mingrong, Liu, Yizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450600/
https://www.ncbi.nlm.nih.gov/pubmed/32854746
http://dx.doi.org/10.1186/s13046-020-01684-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450600/
https://www.ncbi.nlm.nih.gov/pubmed/32854746
http://dx.doi.org/10.1186/s13046-020-01684-x

Ejemplares similares